Review: Resveratrol addiction: To die or not to die

Molecular Nutrition and Food Research

Volumn 53, Issue 1, 2009, Pages 115-128

  Shakibaei, Mehdi ^a   Harikumar, Kuzhuvelil B ^b   Aggarwal, Bharat B ^b  

^a UNIVERSITY OF MUNICH   (Germany)

^b UNIVERSITY OF TEXAS   (United States)

Author keywords

Apoptosis; Inflammation; Mitochondria; Resveratrol; TNF alpha

Indexed keywords

ARACHIS HYPOGAEA; VITACEAE;

ANTINEOPLASTIC AGENT; CARDIOTONIC AGENT; ESTROGEN RECEPTOR; NONSTEROID ANTIINFLAMMATORY AGENT; RESVERATROL; STILBENE DERIVATIVE;

ADDICTION; ANIMAL; APOPTOSIS; CELL CYCLE; CELL DEATH; CELL DIVISION; CELL SURVIVAL; DRUG EFFECT; FRUIT; HUMAN; ISOLATION AND PURIFICATION; REVIEW;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTICARCINOGENIC AGENTS; APOPTOSIS; CARDIOTONIC AGENTS; CELL CYCLE; CELL DEATH; CELL DIVISION; CELL SURVIVAL; FRUIT; HUMANS; RECEPTORS, ESTROGEN; STILBENES; SUBSTANCE-RELATED DISORDERS;

EID: 58149346175     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.200800148     Document Type: Review

References (125)

1. Adcocks, C., Collin, P., Buttle, D. J., Catechins from green tea (Camellia sinensis) inhibit bovine and human cartilage pro-teoglycan and type II collagen degradation in vitro, J. Nutr. 2002, 132, 341-346.
2. Aggarwal, B. B., Takada, Y., Oommen, O. V., From chemo-prevention to chemotherapy: Common targets and common goals, Expert Opin. Investig. Drugs 2004, 13, 1327-1338.
3. Altman, R. D., Marcussen, K. C., Effects of a ginger extract on knee pain in patients with osteoarthritis, Arthritis Rheum. 2001, 44, 2531-2538.
4. Baliga, M. S., Meleth, S., Katiyar, S. K., Growth inhibitory and antimetastatic effect of green tea polyphenols on metastasis-specific mouse mammary carcinoma 4T1 cells in vitro and in vivo systems, Clin. Cancer Res. 2005, 11, 1918-1927.
5. Hur, Y. G., Suh, C. H., Kim, S., Won, J., Rosmarinic acid induces apoptosis of activated T cells from rheumatoid arthritis patients via mitochondrial pathway, J. Clin. Immunol. 2007, 27, 36-45.
6. Ichikawa, H., Takada, Y., Shishodia, S., Jayaprakasam, B. et al., Withanolides potentiate apoptosis, inhibit invasion, and abolish osteoclastogenesis through suppression of nuclear factor-kappaB (NF-kappaB) activation and NF-kappaB-regu-lated gene expression, Mol. Cancer Then 2006, 5, 1434-1445.
7. Kimmatkar, N., Thawani, V, Hingorani, L., Khiyani, R., Efficacy and tolerability of Boswellia serrata extract in treatment of osteoarthritis of knee- a randomized double blind placebo controlled trial, Phytomedicine 2003, 10, 3-7.
8. Riedel, S. B., Fischer, S. M., Sanders, B. G., Kline, K., Vitamin E analog, alpha-tocopherol ether-linked acetic acid analog, alone and in combination with celecoxib, reduces multiplicity of ultraviolet-induced skin cancers in mice, Anticancer Drugs2008, 19, 175-181.
9. Shakibaei, M., John, T., Schulze-Tanzil, G., Lehmann, I., Mobasheri, A., Suppression of NF-kappaB activation by cur-cumin leads to inhibition of expression of cyclo-oxygenase-2 and matrix metalloproteinase-9 in human articular chondro-cytes: Implications for the treatment of osteoarthritis, Bio-chem. Pharmacol 2007, 73, 1434-1445.
10. Shakibaei, M., John, T, Seifarth, C., Mobasheri, A., Resveratrol inhibits IL-1 beta-induced stimulation of caspase-3 and cleavage of PARP in human articular chondrocytes in vitro, Ann. NY Acad. Sci. 2007, 1095, 554-563.
11. Takada, Y., Ichikawa, H., Badmaev, V., Aggarwal, B. B., Ace-tyl-11-keto-beta-boswellic acid potentiates apoptosis, inhibits invasion, and abolishes osteoclastogenesis by suppressing NF-kappa B and NF-kappa B-regulated gene expression, J. Immunol. 2006, 176, 3127-3140.
12. Youn, J., Lee, K. H., Won, I., Huh, S. J. et al, Beneficial effects of rosmarinic acid on suppression of collagen induced arthritis, J. Rheumatol. 2003, 30, 1203-1207.
13. Csaki, C., Keshishzadeh, N., Fischer, K., Shakibaei, M., Regulation of inflammation signalling by resveratrol in human chondrocytes in vitro, Biochem. Pharmacol. 2008, 75, 677-687.
14. Khanna, D., Sethi, G., Ann, K. S., Pandey, M. K. et al., Natural products as a gold mine for arthritis treatment, Curt. Opin. Pharmacol. 2007, 7, 344-351.
15. Baolin, L., Inami, Y., Tanaka, H., Inagaki, N. et al., Resveratrol inhibits the release of mediators from bone marrow-derived mouse mast cells in vitro, Planta Med. 2004, 70, 305-309.
16. Leiro, J., Arranz, J. A., Parana, A., Alvarez, M. E, Sanmartin, M. L., In vitro effects of the polyphenols resveratrol, mangi-ferin and (-)-epigallocatechin-3-gallate on the scuticociliate fish pathogen Philasterides dicentrarchi, Dis. Aquat. Org. 2004, 59, 171-174.
17. Adrian, M., Jeandet, P., Bessis, R., Joubert, J., Induction of phytoalexin (resveratrol) synthesis in grapevine leaves treated with aluminium chloride (A1C13), J. Agric. Food Chem. 1996, 44, 1979-1981.
18. Douillet-Breuil, A. C., Jeandet, P., Adrian, M., Bessis, R., Changes in the phytoalexin content of various Vitis spp. in response to ultraviolet C elicitation, J. Agric. Food Chem. 1999, 47, 4456-4461.
19. Bacaresco, L., Role of viticultural factors on stilbene concentrations of grapes and wine, Drugs Exp. Clin. Res. 2003, 29, 181-187.
20. Aggarwal, B. B., Shishodia, S., Resveratrol in Health and Diseases, CRC Press, Boca Raton 2006.
21. Harikumar, K. B., Aggarwal, B. B., Resveratrol: A multitar-geted agent for age-associated chronic diseases, Cell Cycle 2008, 7, 1020-1035.
22. Rahman, I., Biswas, S. K., Kirkham, P. A., Regulation of inflammation and redox signaling by dietary polyphenols, Biochem. Pharmacol. 2006, 72, 1439-1452.
23. Andlauer, W., Kolb, I., Siebert, K., Furst, P., Assessment of resveratrol bioavailability in the perfused small intestine of the rat, Drugs Exp. Clin. Res. 2000, 26, 47-55.
24. VitraC, X., Desmouliere, A., Brouillaud, B., Krisa, S. et al, Distribution of [14C]-trans-resveratrol, a cancer chemopreventive polyphenol, in mouse tissues after oral administration, Life Sci. 2003, 72, 2219-2233.
25. Aggarwal, B. B., Bhardwaj, A., Aggarwal, R. S., Seeram, N. P. et al, Role of resveratrol in prevention and therapy of cancer: Preclinical and clinical studies, Anticancer Res. 2004, 24, 2783-2840.
26. Yu, C., Shin, Y. G., Chow, A., Li, Y. et al., Human, rat, and mouse metabolism of resveratrol, Pharm. Res. 2002, 19, 1907-1914.
27. Jang, M., Cai, L., Udeani, G. O., Slowing, K. V. et al., Cancer chemopreventive activity of resveratrol, a natural product derived from grapes, Science 1997, 275, 218-220.
28. Martinez, J., Moreno, J. J., Effect of resveratrol, a natural pol-yphenolic compound, on reactive oxygen species and prosta-glandin production, Biochem. Pharmacol. 2000, 59, 865-870.
29. Dai, Z., Li, Y., Quarles, L. D., Song, T. et al., Resveratrol enhances proliferation and osteoblastic differentiation in human mesenchymal stem cells via ER-dependent ERK1/2 activation, Phytomedicine 2007, 14, 806-814.
30. Adrian, M., Jeandet, P., Bessis, R., Joubert, J., Induction of phytoalexin (resveratrol) synthesis in grapevine leaves treated with aluminium chloride (AlCl3), J. Agric. Food Chem. 1996, 44, 1979-1981.
31. Cantos, E., Garcia-Viguera, C., de Pascual-Teresa, S., Tomas-Barberan, F A., Effect of postharvest ultraviolet irradiation on resveratrol and other phenolics of cv. Napoleon table grapes, J., Agric. Food Chem. 2000, 48, 4606-4612.
32. Donnelly, L. E., Newton, R., Kennedy, G. E., Fenwick, P. S. et al., Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms, Am. J. Physiol. Lung Cell. Mol. Physiol 2004, 287, L774-783.
33. Surh, Y. J., Cancer chemoprevention with dietary phytochem-icals, Nat. Rev. Cancer, 2003 3, 768-780.
34. Athar, M., Back, J. H., Tang, X., Kim, K. H. et al., Resveratrol: A review of preclinical studies for human cancer prevention, Toxicol. Appl. Pharmacol. 2007, 224, 274-283.
35. Sarkar, F. H., Li, Y., Cell signaling pathways altered by natural chemopreventive agents, Mutat. Res. 2004, 555, 53-64.
36. Bode, A. M., Dong, Z., Targeting signal transduction pathways by chemopreventive agents, Mutat. Res. 2004, 555, 33-51.
37. Delmas, D., Lancon, A., Colin, D., Jannin, B., Latruffe, N., Resveratrol as a chemopreventive agent: A promising molecule for fighting cancer, Curr. Drug Targets 2006, 7, 423-442.
38. Baur, J. A., Sinclair, D. A., Therapeutic potential of resveratrol: The in vivo evidence, Nat. Rev. Drug Discov. 2006, 5, 493-506.
39. Shankar, S., Singh, G., Srivastava, R. K., Chemoprevention by resveratrol: Molecular mechanisms and therapeutic potential, Front Biosci. 2007, 12, 4839-4854.
40. de la Lastra, C. A., Villegas, I., Resveratrol as an anti-inflammatory and anti-aging agent: Mechanisms and clinical implications, Mol. Nutr. Food Res. 2005, 49, 405-430.
41. Meeran, S. M., Katiyar, S. K., Cell cycle control as a basis for cancer chemoprevention through dietary agents, Front Biosci. 2008, 73, 2191-2202.
42. Lowe, S. W., Lin, A. W., Apoptosis in cancer, Carcinogenesis 2000, 21, 485-495.
43. van Ginkel, P. R., Sareen, D., Subramanian, L., Walker, Q. et al., Resveratrol inhibits tumor growth of human neuroblas-toma and mediates apoptosis by directly targeting mitochondria, Clin. Cancer Res. 2007, 13, 5162-5169.
44. Sareen, D., van Ginkel, P. R., Takach, J. C., Mohiuddin, A. et al., Mitochondria as the primary target of resveratrol-induced apoptosis in human retinoblastoma cells, Invest. Ophthalmol. Vis. Sci. 2006, 47, 3708-3716.
45. Banerjee, S., Bueso-Ramos, C., Aggarwal, B. B., Suppression of 7, 12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: Role of nuclear factor-kap-paB, cyclooxygenase 2, and matrix metalloprotease 9, Cancer Res. 2002, 62, 4945-4954.
46. Fulda, S., Debatin, K. M., Sensitization for tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by the chemopreventive agent resveratrol, Cancer Res. 2004, 64, 337-346.
47. Fulda, S., Debatin, K. M., Resveratrol modulation of signal transduction in apoptosis and cell survival: A mini-review. Cancer Detect Prev. 2006, 30, 217-223.
48. Schneider, Y., Duranton, B., Gosse, E, Schleiffer, R. et al., Resveratrol inhibits intestinal tumorigenesis and modulates host-defense-related gene expression in an animal model of human familial adenomatous polyposis, Nutr. Cancer 2001, 39, 102-107.
49. Tang, H. Y., Shih, A., Cao, H. J., Davis, E B. et al., Resveratrol-induced cyclooxygenase-2 facilitates p53-dependent apoptosis in human breast cancer cells, Mol. Cancer Ther. 2006, 5, 2034-2042.
50. Aggarwal, B. B., Takada, Y., Shishodia, S., Gutierrez, A. M. et al., Nuclear transcription factor NF-kappa B: Role in biology and medicine, Indian J. Exp. Biol. 2004, 42, 341-353.
51. Aggarwal, B. B., Shishodia, S., Sandur, S. K., Pandey, M. K., Sethi, G., Inflammation and cancer: How hot is the link? Biochem. Pharmacol. 2006, 72, 1605-1621.
52. Manna, S. K., Mukhopadhyay, A., Aggarwal, B. B., Resveratrol suppresses TNF-induced activation of nuclear transcription factors NF-kappa B, activator protein-1, and apoptosis: Potential role of reactive oxygen intermediates and lipid per-oxidation, J. Immunol 2000, 164, 6509-6519.
53. Kim, Y. A., Rhee, S. H., Park, K. Y., Choi, Y. H., Antiproliferative effect of resveratrol in human prostate carcinoma cells, J. Med. Food, 2003 6, 273-280.
54. Bhardwaj, A., Sethi, G., Vadhan-Raj, S., Bueso-Ramos, C. et al., Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells, Blood 2007, 709, 2293-2302.
55. Zhou, H. B., Chen, J. J., Wang, W. X., Cai, J. T., Du, Q. Anticancer activity of resveratrol on implanted human primary gastric carcinoma cells in nude mice, World J. Gastroenterol. 2005, 11, 280-284.
56. Fuggetta, M. P., Lanzilli, G., Tricarico, M., Cottarelli, A. et al., Effect of resveratrol on proliferation and telomerase activity of human colon cancer cells in vitro, J. Exp. Clin. Cancer Res. 2006, 25, 189-193.
57. Lanzilli, G., Fuggetta, M. P., Tricarico, M., Cottarelli, A. et al., Resveratrol down-regulates the growth and telomerase activity of breast cancer cells in vitro, Int. J. Oncol. 2006, 28, 641-648.
58. Pozo-Guisado, E., Merino, J. M., Mulero-Navarro, S., Lorenzo-Benayas, M. J. et al., Resveratrol-induced apoptosis in MCF-7 human breast cancer cells involves a caspase-inde-pendent mechanism with downregulation of Bcl-2 and NF-kappaB, Int. J. Cancer 2005, 115, 74-84.
59. Kim, A. L., Zhu, Y., Zhu, H., Han, L. et al., Resveratrol inhibits proliferation of human epidermoid carcinoma A431 cells by modulating MEKl and AP-l signalling pathways, Exp. Dermatol. 2006, 15, 538-546.
60. Ahmad, N., Adhami, V. M., Afaq, F., Feyes, D. K., Mukhtar, 11., Resveratrol causes WAF-l/p21-mediated G(l)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells, Clin. Cancer Res. 2001, 7, 1466-1473.
61. Yang, S., Meyskens, F. L., Jr., Alterations in activating protein 1 composition correlate with phenotypic differentiation changes induced by resveratrol in human melanoma, Mol. Pharmacol. 2005, 67, 298-308.
62. Kundu, J. K., Shin, Y. K., Kim, S. H., Surh, Y. J., Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-kappaB in mouse skin by blocking IkappaB kinase activity, Carcinogenesis 2006, 27, 1465-1474.
63. Kundu, J. K., Shin, Y. K., Surh, Y. J., Resveratrol modulates phorbol ester-induced pro-inflammatory signal transduction pathways in mouse skin in vivo: NF-kappaB and AP-1 as prime targets, Biochem. Pharmacol. 2006, 72, 1506-1515.
64. Bhat, K. P., Pezzuto, J. M., Cancer chemopreventive activity of resveratrol, Ann. NY Acad. Sci. 2002, 957, 210-229.
65. Subbaramaiah, K., Chung, W. J., Michaluart, P., Telang, N. et al., Resveratrol inhibits cyclooxygenase-2 transcription and activity in phorbol ester-treated human mammary epithelial cells, J. Biol. Chem. 1998, 273, 21875-21882.
66. Subbaramaiah, K., Michaluart, P., Chung, W. J., Tanabe, T. et al., Resveratrol inhibits cyclooxygenase-2 transcription in human mammary epithelial cells, Ann. NY Acad. Sci. 1999, 889, 214-223.
67. Fulda, S., Debatin, K. M., Sensitization for anticancer drug-induced apoptosis by the chemopreventive agent resveratrol, Oncogene 2004, 23, 6702-6711.
68. Gatz, S. A., Keimling, M., Baumann, C., Dork, T. et al., Resveratrol modulates DNA double-strand break repair pathways in an ATM/ATR-p53- and -Nbsl-dependent manner, Carcinogenesis 2008, 29, 519-527.
69. Kastan, M. B., Onyekwere, O., Sidransky, D., Vogelstein, B., Craig, R. W., Participation of p53 protein in the cellular response to DNA damage, Cancer Res. 1991, 51, 6304-6311.
70. Ivanov, G. S., Ivanova, T., Kurash, J., Ivanov, A. et al., Methylation-acetylation interplay activates p53 in response to DNA damage, Mol. Cell. Biol. 2007, 27, 6756-6769.
71. Huang, C., Ma, W. Y., Goranson, A., Dong, Z., Resveratrol suppresses cell transformation and induces apoptosis through a p53-dependent pathway, Carcinogenesis 1999, 20, 237-242.
72. Lin, H. Y., Shih, A., Davis, F. B., Tang, H. Y. et al., Resveratrol induced serine phosphorylation of p53 causes apoptosis in a mutant p53 prostate cancer cell line, J. Urol. 2002, 168, 748-755.
73. She, Q. B., Bode, A. M., Ma, W. Y., Chen, N. Y., Dong, Z., Resveratrol-induced activation of p53 and apoptosis is mediated by extracellular-signal-regulated protein kinases and p38 kinase, Cancer Res. 2001, 61, 1604-1610.
74. Zhang, S., Cao, H. J., Davis, F. B., Tang, H. Y. et al., Oestrogen inhibits resveratrol-induced post-translational modification of p53 and apoptosis in breast cancer cells, Br. J. Cancer 2004, 91, 178-185.
75. Delia Ragione, F., Cucciolla, V., Criniti, V., Indaco, S. et al., Antioxidants induce different phenotypes by a distinct modulation of signal transduction, FEBS Lett. 2002, 532, 289-294.
76. Ulrich, S., Loitsch, S. M., Rau, O., von Knethen, A. et al., Peroxisome proliferator-activated receptor gamma as a molecular target of resveratrol-induced modulation of polyamine metabolism, Cancer Res. 2006, 66, 7348-7354.
77. Kotha, A., Sekharam, M., Cilenti, L., Siddiquee, K. et al., Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein, Mol. Cancer Ther. 2006, 5, 621-629.
78. Wung, B. S., Hsu, M. C., Wu, C. C., Hsieh, C. W., Resveratrol suppresses IL-6-induced ICAM-1 gene expression in endo-thelial cells: Effects on the inhibition of STAT3 phosphorylation, Life Sci. 2005, 78, 389-397.
79. Kim, S. H., Park, H. S., Lee, M. S., Cho, Y. J. et al., Vitisin A inhibits adipocyte differentiation through cell cycle arrest in 3T3-L1 cells, Biochem. Biophys. Res. Commun. 2008, 372, 108-113.
80. Yang, J. Y., Della-Fera, M. A., Rayalam, S., Ambati, S. et al., Enhanced inhibition of adipogenesis and induction of apoptosis in 3T3-L1 adipocytes with combinations of resveratrol and quercetin, Life Sci. 2008, 82, 1032-1039.
81. Provinciali, M., Re, F., Donnini, A., Orlando, F. et al., Effect of resveratrol on the development of spontaneous mammary tumors in HER-2/neu transgenic mice, Int. J. Cancer 2005, 115, 36-45.
82. Garvin, S., Ollinger, K., Dabrosin, C., Resveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo, Cancer Lett. 2006, 231, 113-122.
83. Sato, M., Pei, R. J., Yuri, T., Danbara, N. et al., Prepubertal resveratrol exposure accelerates N-methyl-N-nitrosourea-induced mammary carcinoma in female Sprague-Dawley rats, Cancer Lett. 2003, 202, 137-145.
84. Gehm, B. D., McAndrews, J. M., Chien, P. Y., Jameson, J. L., Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor, Proc. Natl. Acad. Sci. USA 1997, 94, 14138-14143.
85. Bhat, K. P., Lantvit, D., Christov, K., Mehta, R. G. et al., Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models, Cancer Res. 2001, 61, 7456-7463.
86. Pozo-Guisado, E., Lorenzo-Benayas, M. J., Fernandez-Salguero, P. M., Resveratrol modulates the phosphoinositide 3-kinase pathway through an estrogen receptor alpha-dependent mechanism: Relevance in cell proliferation, Int. J. Cancer 2004, 109, 167-173.
87. El-Mowafy, A. M., White, R. E., Resveratrol inhibits MAPK activity and nuclear translocation in coronary artery smooth muscle: Reversal of endothelin-1 stimulatory effects, FEBS Lett. 1999, 451, 63-67.
88. Trosko, J. E., Ruch, R. J., Gap junctions as targets for cancer chemoprevention and chemotherapy, Curr. Drug Targets 2002, 3, 465-482.
89. Nielsen, M., Ruch, R. J., Vang, O., Resveratrol reverses tumor-promoter-induced inhibition of gap-junctional intercellular communication, Biochem. Biophys. Res. Commun. 2000, 275, 804-809.
90. Yan, F., Tian, X. M., Ma, X. D., Effects of resveratrol on growth inhibition and gap-junctional intercellular communication of HepG2 cells, Nan Fang Yi Ke Da Xue Xue Bao 2006, 26, 963-966.
91. Leone, S., Fiore, M., Lauro, M. G., Pino, S. et al., Resveratrol and X rays affect gap junction intercellular communications in human glioblastoma cells, Mol. Carcinog. 2008, 47, 587-598.
92. Das, S., Das, D. K., Resveratrol: A therapeutic promise for cardiovascular diseases, Recent Patents Cardiovasc. Drug Discov. 2007, 2, 133-138.
93. Lee, B., Moon, S. K., Resveratrol inhibits TNF-alpha-induced proliferation and matrix metalloproteinase expression in human vascular smooth muscle cells, J. Nutr. 2005, 135, 2767-2773.
94. Martin, A. R., Villegas, I., Sanchez-Hidalgo, M., de la Lastra, C. A., The effects of resveratrol, a phytoalexin derived from red wines, on chronic inflammation induced in an experimentally induced colitis model, Br. J. Pharmacol. 2006, 147, 873-885.
95. Rahman, I., Marwick, J., Kirkham, P., Redox modulation of chromatin remodeling: Impact on histone acetylation and deacetylation, NF-kappaB and proinflammatory gene expression, Biochem. Pharmacol. 2004, 68, 1255-1267.
96. Pinto, M. C., Garcia-Barrado, J. A., Macias, P., Resveratrol is a potent inhibitor of the dioxygenase activity of lipoxygenase, J. Agric. Food Chem. 1999, 47, 4842-4846.
97. Hattori, R., Otani, H., Maulik, N., Das, D. K., Pharmacological preconditioning with resveratrol: Role of nitric oxide, Am. J. Physiol. Heart Circ. Physiol. 2002, 282, H1988-H1995.
98. Renaud, S., de Lorgeril, M., Wine, alcohol, platelets, and the French paradox for coronary heart disease, Lancet 1992, 339, 1523-1526.
99. Ray, P. S., Maulik, G., Cordis, G. A., Bertelli, A. A. et al., The red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury, Free Radic. Biol. Med. 1999, 27, 160-169.
100. Lekli, I., Szabo, G., Juhasz, B., Das, S. et al., Protective mechanisms of resveratrol against ischemia-reperfusion-induced damage in hearts obtained from Zucker obese rats: The role of GLUT-4 and endothelin, Am. J. Physiol. Heart Circ. Physiol. 2008, 294, H859-H866.
101. Penumathsa, S. V, Thirunavukkarasu, M., Koneru, S., Juhasz, B. et al., Statin and resveratrol in combination induces cardioprotection against myocardial infarction in hypercholesterolemic rat, J. Mol. Cell. Cardiol. 2007, 42, 508-516.
102. Lin, J. K., Tsai, S. H., Chemoprevention of cancer and cardiovascular disease by resveratrol, Proc. Natl. Sci. Counc. Repub. China B 1999, 23, 99-106.
103. Das, S., Khan, N., Mukherjee, S., Bagchi, D. et al., Redox regulation of resveratrol-mediated switching of death signal into survival signal, Free Radic. Biol. Med. 2008, 44, 82-90.
104. Thirunavukkarasu, M., Penumathsa, S. V, Koneru, S., Juhasz, B. et al., Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenase, Free Radic. Biol. Med. 2007, 43, 720-729.
105. Tang, X., Liu, D., Shishodia, S., Ozburn, N. et al., Nuclear factor-kappaB (NF-kappaB) is frequently expressed in lung cancer and preneoplastic lesions, Cancer 2006, 107, 2637-2646.
106. Kaga, S., Zhan, L., Matsumoto, M., Maulik, N., Resveratrol enhances neovascularization in the infarcted rat myocardium through the induction of thioredoxin-1, heme oxygenase-1 and vascular endothelial growth factor, J. Mol. Cell. Cardiol. 2005, 39, 813-822.
107. Cullen, J. P., Morrow, D., Jin, Y., von Offenberg Sweeney, N. et al., Resveratrol inhibits expression and binding activity of the monocyte chemotactic protein-1 receptor, CCR2, on THP-l monocytes, Atherosclerosis 2007, 195, e125-e133.
108. Cullen, J. P., Morrow, D., Jin, Y., Curley, B. et al., Resveratrol, a polyphenolic phytostilbene, inhibits endothelial monocyte chemotactic protein-1 synthesis and secretion, J. Vase. Res. 2007, 44, 75-84.
109. Imamura, G., Bertelli, A. A., Bertelli, A., Otani, H. et al., Pharmacological preconditioning with resveratrol: An insight with iNOS knockout mice, Am. J. Physiol. Heart Circ. Physiol. 2002, 282, H1996-H2003.
110. Hung, L. M., Su, M. J., Chen, J. K., Resveratrol protects myocardial ischemia-reperfusion injury through both NO-dependent and NO-independent mechanisms, Free Radic. Biol. Med. 2004, 36, 774-781.
111. Malemud, C. J., Inhibitors of stress-activated protein/mitogen-activated protein kinase pathways, Curr. Opin. Pharmacol. 2007, 7, 339-343.
112. Das, D. K., Maulik, N., Resveratrol in cardioprotection: A therapeutic promise of alternative medicine, Mol. Interv. 2006, 6, 36-47.
113. Das, S., Tosaki, A., Bagchi, D., Maulik, N., Das, D. K., Potentiation of a survival signal in the ischemic heart by resveratrol through p38 mitogen-activated protein kinase/ mitogen- and stress-activated protein kinase 1/cAMP response element-binding protein signaling, J. Pharmacol. Exp. Ther. 2006, 317, 980-988.
114. Wang, Z., Zou, J., Huang, Y., Cao, K. et al., Effect of resveratrol on platelet aggregation in vivo and in vitro, Chin. Med. J. (Engl) 2002, 115, 378-380.
115. Shigematsu, S., Ishida, S., Hara, M., Takahashi, N. et al., Resveratrol, a red wine constituent polyphenol, prevents superoxide-dependent inflammatory responses induced by ischemia/reperfusion, platelet-activating factor, or oxidants, Free Radic. Biol. Med. 2003, 34, 810-817.
116. Sato, M., Maulik, G., Bagchi, D., Das, D. K., Myocardial protection by protykin, a novel extract of trans-resveratrol and emodin, Free Radio. Res. 2000, 32, 135-144.
117. Xie, W. L., Chipman, J. G., Robertson, D. L., Erikson, R. L., Simmons, D. L., Expression of a mitogen-responsive gene encoding prostaglandin synthase is regulated by mRNA splicing. Proc. Natl. Acad. Sei USA 1991, 88, 2692-2696.
118. Elmali, N., Baysal, O., Harma, A., Esenkaya, I., Mizrak, B., Effects of resveratrol in inflammatory arthritis, Inflamma-tion 2007, 30, 1-6.
119. Elmali, N., Esenkaya, L, Harma, A., Ertem, K. et al., Effect of resveratrol in experimental osteoarthritis in rabbits, Inflamm. Res. 2005, 54, 158-162.
120. Tang, L. L., Gao, J. S., Chen, X. R., Xie, X., Inhibitory effect of resveratrol on the proliferation of synoviocytes in rheumatoid arthritis and its mechanism in vitro, Zhong Nan Da Xue Xue Bao Yi Xue Ban 2006, 31, 528-533.
121. Howitz, K. T., Bitterman, K. J., Cohen, H. Y., Lamming, D. W. et al., Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan, Nature 2003, 425, 191-196.
122. Barger, J. L., Kayo, T., Vann, J. M., Arias, E. B. et al., A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice, PLoS ONE 2008, 3, e2264.
123. Wood, J. G., Rogina, B., Lavu, S., Howitz, K. et al., Sirtuin activators mimic caloric restriction and delay ageing in metazoans, Nature 2004, 430, 686-689.
124. Valenzano, D. R., Terzibasi, E., Genade, T., Cattaneo, A. et al., Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate, Curr. Biol. 2006, 16, 296-300.
125. Le Corre, L., Chalabi, N., Delort, L., Bignon, Y. J. et al., Resveratrol and breast cancer chemoprevention: Molecular mechanisms, Mol. Nutr. Food Res. 2005, 49, 462-471.